Ameriprise’s Invesco Bloomberg Analyst Rating Improvers ETF UPGD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-11,555
Closed -$376K 3881
2015
Q4
$376K Sell
11,555
-3,286
-22% -$111K ﹤0.01% 3388
2015
Q3
$477K Buy
14,841
+3,114
+27% +$109K ﹤0.01% 3290
2015
Q2
$430K Buy
11,727
+458
+4% +$17K ﹤0.01% 3507
2015
Q1
$412K Buy
11,269
+546
+5% +$19.2K ﹤0.01% 3289
2014
Q4
$375K Sell
10,723
-1,000
-9% -$33.9K ﹤0.01% 3238
2014
Q3
$396K Buy
11,723
+27
+0.2% +$935 ﹤0.01% 3113
2014
Q2
$413K Buy
11,696
+180
+2% +$6.08K ﹤0.01% 3061
2014
Q1
$396K Buy
11,516
+4,361
+61% +$147K ﹤0.01% 3027
2013
Q4
$240K Buy
7,155
+815
+13% +$26K ﹤0.01% 3080
2013
Q3
$195K Buy
6,340
+1,540
+32% +$45.9K ﹤0.01% 3193
2013
Q2
$136K Buy
+4,800
New +$130K ﹤0.01% 3250

Other funds holding UPGD

Ameriprise's UPGD Position: Q1 2016 in Review

Ameriprise sold out of Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) in Q1 2016, closing a stake of 11,555 shares — an estimated $376K sold.

Ameriprise first reported a position in UPGD in Q2 2013 and held it in 11 quarters. The position peaked at $477K in Q3 2015. 26 funds tracked by Wall St. Rank hold UPGD as of Q1 2016.

  • Ameriprise reported no remaining Invesco Bloomberg Analyst Rating Improvers ETF position as of Q1 2016 after selling out during the quarter.
  • Ameriprise sold 11,555 Invesco Bloomberg Analyst Rating Improvers ETF shares in Q1 2016, an estimated $376K.
  • Ameriprise first reported a position in Invesco Bloomberg Analyst Rating Improvers ETF in Q2 2013 and held it in 11 quarters.
  • Ameriprise's Invesco Bloomberg Analyst Rating Improvers ETF position peaked at $477K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held Invesco Bloomberg Analyst Rating Improvers ETF as of Q1 2016.

Based on Ameriprise's 13F filing for Q1 2016, filed 12 May 2016.